Laura Colón is President of AstraZeneca Spain, where she leads the strategy to drive scientific development, accelerate access to new treatments, and strengthen the company’s contribution to the healthcare system, thereby consolidating Spain’s role as a priority location within the global strategy. She also serves as Site Leader for the AstraZeneca Global Hub in Barcelona, a driving force for biomedical, digital, and commercial innovation in Europe. With a projected investment of €1.3 billion through 2027 and a workforce of over 1,600 employees, the Hub integrates biomedicine, data science, digital innovation, and commercial excellence, contributing to the global goal of making 20 new medicines available to patients before the end of the decade.
Her vision is rooted in the conviction that science transforms lives and that innovation only gains value when it reaches patients and strengthens health systems. Her leadership combines excellence and a results-oriented approach with a people-centric, approachable management style, fostering diverse and balanced environments, talent development, and a culture committed to sustainability and social progress.
Prior to assuming the presidency, she led the Oncology division in Spain, driving the introduction of new treatments and the expansion of indications for conditions with high unmet medical needs—achievements recognized in Merco’s 2025 Health Reputation Monitor (MRS).
Colón has over 20 years of experience in the pharmaceutical industry, having held senior roles in both Spain and international markets. She joined AstraZeneca in 2019 to lead the Lung Cancer franchise and, in 2021, relocated to Singapore to serve as International Director for the Lung, Gastrointestinal, Genitourinary, and Gynecological Cancer franchises, developing an impact-oriented, cross-functional view of the business.
Earlier in her career, she worked at companies such as Roche, Biogen, and AbbVie. She holds a degree in Psychology from the Autonomous University of Madrid and has completed executive training in business, strategy, and innovation.